As many of my readers know, I’m fascinated by implantable medical devices. Frankly, my artistic alter-ego is a futurist, and esthetically I love the prospect of our society increasingly turning to cyborg-ism as our concept of normative health expands ever towards having the health of a younger person at an older age.
Today’s IMD news is that there is a new executive VP heading Medtronic’s cardiology section. Michael Coyle formerly of rival St. Jude Medical (which also produces pacemakers and implantable cardioverter defibrillators) will take the helm.
From the geek angle, I wonder what – if any – change this will mean in their R&D labs. Medtronic has always been a wonderful company to interact with as a researcher, they even sent a representative to this year’s new ACM workshop on health security SPIMACS. I’m hoping that the new management will continue working well with external researchers who work with their products.
More info: Press Release
Newspaper article: http://www.twincities.com/business/ci_13913830
